Breaking News Instant updates and real-time market news.

SNN

Smith & Nephew

$37.12 /

-0.18 (-0.48%)

15:05
09/10/21
09/10
15:05
09/10/21
15:05

Smith & Nephew price target lowered to 1,800 GBp from 1,825 GBp at Barclays

Barclays analyst Hassan Al-Wakeel lowered the firm's price target on Smith & Nephew to 1,800 GBp from 1,825 GBp and keeps an Overweight rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

General news
U.S. durable goods preview » 06:45
06/27/22
06/27
06:45
06/27/22
06:45
$ECON

Economic Data

/

+

U.S. durable goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. pending home sales preview » 06:45
06/27/22
06/27
06:45
06/27/22
06:45
$ECON

Economic Data

/

+

U.S. pending home sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Otis Worldwide appoints Anurag Maheshwari EVP, CFO » 06:42
06/27/22
06/27
06:42
06/27/22
06:42
OTIS

Otis Worldwide

$70.83 /

+2.25 (+3.28%)

Otis Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

06/22/22 Berenberg
Otis Worldwide price target lowered to $80 from $88 at Berenberg
05/24/22 Barclays
Otis Worldwide upgraded to Overweight from Equal Weight at Barclays
04/26/22 Cowen
Otis Worldwide price target lowered to $85 from $91 at Cowen
04/26/22 Barclays
Otis Worldwide price target lowered to $80 from $88 at Barclays
OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

Initiation
Darden reinstated with a Buy at BofA » 06:41
06/27/22
06/27
06:41
06/27/22
06:41
DRI

Darden

$119.79 /

+4.17 (+3.61%)

BofA analyst Katherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$119.79 /

+4.17 (+3.61%)

DRI Darden
$119.79 /

+4.17 (+3.61%)

06:38 Today BofA
Correction: Darden reinstated with a Buy at BofA
06/24/22 BMO Capital
Darden price target lowered to $130 from $140 at BMO Capital
06/24/22 RBC Capital
Darden price target lowered to $143 from $151 at RBC Capital
06/24/22 Morgan Stanley
Darden price target lowered to $148 from $161 at Morgan Stanley
DRI Darden
$119.79 /

+4.17 (+3.61%)

DRI Darden
$119.79 /

+4.17 (+3.61%)

Syndicate
Cerberus Cyber files $300M mixed securities shelf  06:40
06/27/22
06/27
06:40
06/27/22
06:40
CISO

Cerberus Cyber

$5.26 /

-0.22 (-4.01%)

 
ShowHide Related Items >><<
CISO Cerberus Cyber
$5.26 /

-0.22 (-4.01%)

  • 14
    Jan
CISO Cerberus Cyber
$5.26 /

-0.22 (-4.01%)

Recommendations
FedEx price target raised to $339 from $328 at Loop Capital » 06:39
06/27/22
06/27
06:39
06/27/22
06:39
FDX

FedEx

$243.26 /

+15.71 (+6.90%)

Loop Capital analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

06/24/22 BofA
FedEx price target raised to $276 from $265 at BofA
06/24/22 Wells Fargo
FedEx price target raised to $282 from $277 at Wells Fargo
06/24/22 UBS
FedEx price target raised to $312 from $300 at UBS
06/24/22 JPMorgan
FedEx price target raised to $284 from $279 at JPMorgan
FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

Recommendations
Reynolds Consumer Products price target lowered to $28 from $31 at Citi » 06:38
06/27/22
06/27
06:38
06/27/22
06:38
REYN

Reynolds Consumer Products

$27.37 /

+0.37 (+1.37%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
03/29/22 Goldman Sachs
Reynolds Consumer Products downgraded to Sell from Buy at Goldman Sachs
REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

Upgrade
Vermilion Energy upgraded to Outperform from Sector Perform at Scotiabank » 06:37
06/27/22
06/27
06:37
06/27/22
06:37
VET

Vermilion Energy

$17.86 /

+0.86 (+5.06%)

Scotiabank analyst Gavin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

06/16/22 National Bank
Vermilion Energy price target lowered to C$52 from C$53 at National Bank
06/15/22 CIBC
Vermilion Energy price target raised to C$34 from C$32 at CIBC
06/08/22 Scotiabank
Vermilion Energy price target raised to C$36 from C$30 at Scotiabank
06/02/22 CIBC
Vermilion Energy price target raised to C$32 from C$25 at CIBC
VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

Initiation
Enovis assumed with a Buy at Loop Capital » 06:37
06/27/22
06/27
06:37
06/27/22
06:37
ENOV

Enovis

$58.28 /

+2.84 (+5.12%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENOV Enovis
$58.28 /

+2.84 (+5.12%)

ENOV Enovis
$58.28 /

+2.84 (+5.12%)

06/16/22 Wells Fargo
Enovis initiated with an Equal Weight, $61 price target at Wells Fargo
06/16/22 Wells Fargo
Enovis initiated with an Equal Weight at Wells Fargo
05/13/22 Loop Capital
ESAB initiated with a Hold at Loop Capital
05/11/22 Baird
Enovis price target lowered to $73 from $79 at Baird
ENOV Enovis
$58.28 /

+2.84 (+5.12%)

ENOV Enovis
$58.28 /

+2.84 (+5.12%)

Recommendations
Citi cuts S&P 500 year-end target, sees positive second half setup » 06:36
06/27/22
06/27
06:36
06/27/22
06:36
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$390.07 /

+11.955 (+3.16%)

Citi analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
02/18/22 Stifel
Stifel says S&P 500 correction in Q1 isn't over
02/17/22 JPMorgan
JPMorgan now expects seven rate hikes in this year, up from five
SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
02/18/22 Stifel
Stifel says S&P 500 correction in Q1 isn't over
02/17/22 JPMorgan
JPMorgan now expects seven rate hikes in this year, up from five
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

Hot Stocks
Cemex launches new Green Financing Framework » 06:36
06/27/22
06/27
06:36
06/27/22
06:36
CX

Cemex

$3.90 /

+0.165 (+4.42%)

CEMEX announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CX Cemex
$3.90 /

+0.165 (+4.42%)

CX Cemex
$3.90 /

+0.165 (+4.42%)

06/10/22 Berenberg
Cemex downgraded to Hold from Buy at Berenberg
04/20/22 Credit Suisse
Cemex upgraded to Outperform from Neutral at Credit Suisse
04/04/22 Goldman Sachs
Cemex downgraded to Neutral from Buy at Goldman Sachs
02/23/22 Credit Suisse
Cemex downgraded to Neutral from Outperform at Credit Suisse
Initiation
Brinker reinstated with an Underperform at BofA » 06:35
06/27/22
06/27
06:35
06/27/22
06:35
EAT

Brinker

$23.94 /

+0.345 (+1.46%)

BofA analyst Sara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

06:12 Today BofA
Brinker reinstated with an Underperform at BofA
06/16/22 Citi
Brinker price target lowered to $27 from $40 at Citi
06/09/22 Barclays
Brinker price target lowered to $34 from $38 at Barclays
06/03/22 MKM Partners
Brinker price target lowered to $40 from $45 at MKM Partners
EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

Recommendations
Warby Parker price target lowered to $15 from $18 at Loop Capital » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
WRBY

Warby Parker

$13.94 /

+0.465 (+3.45%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

05/17/22 Goldman Sachs
Warby Parker downgraded to Neutral from Buy at Goldman Sachs
05/17/22 Baird
Warby Parker price target lowered to $30 from $40 at Baird
05/17/22 Citi
Warby Parker price target lowered to $29 from $41 at Citi
03/30/22 Stifel
Warby Parker initiated with a Hold at Stifel
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

  • 29
    Sep
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

Hot Stocks
BiomX announces dosing of first two patients in Phase 1b/2a study of BX004 » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
PHGE

BiomX

/

+

BiomX announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHGE BiomX
/

+

PHGE BiomX
/

+

05/12/22 Ladenburg
BiomX price target lowered to $8 from $13 at Ladenburg
03/31/22 Chardan
BiomX price target lowered to $12 from $13 at Chardan
10/19/21 Chardan
BiomX price target lowered to $16 from $28 at Chardan
10/18/21 H.C. Wainwright
BiomX price target lowered to $10 from $20 at H.C. Wainwright
Hot Stocks
Beam Therapeutics to present new research at FASEB conference » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
BEAM

Beam Therapeutics

$42.55 /

+0.985 (+2.37%)

Beam Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

06/16/22 BMO Capital
Beam Therapeutics initiated with a Market Perform at BMO Capital
04/28/22 Credit Suisse
Beam Therapeutics initiated with a Neutral at Credit Suisse
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
01/05/22 Guggenheim
Guggenheim starts Beam Therapeutics with a Buy rating, $130 price target
BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

Hot Stocks
Volta appoints Tang as Chief Technology Officer » 06:33
06/27/22
06/27
06:33
06/27/22
06:33
VLTA

Volta

$1.67 /

-0.035 (-2.05%)

Volta announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLTA Volta
$1.67 /

-0.035 (-2.05%)

VLTA Volta
$1.67 /

-0.035 (-2.05%)

06/13/22 Cantor Fitzgerald
Volta downgraded to Neutral at Cantor Fitzgerald as CFO departs
06/13/22 Cantor Fitzgerald
Volta downgraded to Neutral from Overweight at Cantor Fitzgerald
05/18/22 Cantor Fitzgerald
Volta price target lowered to $6 from $8 at Cantor Fitzgerald
05/16/22 Roth Capital
Volta still an active target for takeover, says Roth Capital
VLTA Volta
$1.67 /

-0.035 (-2.05%)

VLTA Volta
$1.67 /

-0.035 (-2.05%)

VLTA Volta
$1.67 /

-0.035 (-2.05%)

Hot Stocks
FF Top Holding delivers notice of removal of Krolicki from Faraday Future board » 06:33
06/27/22
06/27
06:33
06/27/22
06:33
FFIE

Faraday Future

$2.47 /

+0.02 (+0.82%)

FF Top Holding LLC, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FFIE Faraday Future
$2.47 /

+0.02 (+0.82%)

FFIE Faraday Future
$2.47 /

+0.02 (+0.82%)

11/16/21 Wedbush
Wedbush downgrades Faraday Future to Neutral, sees shares in 'penalty box'
11/16/21 Wedbush
Faraday Future downgraded to Neutral from Outperform at Wedbush
10/25/21 Wedbush
Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush
08/17/21 Wedbush
Wedbush bullish on Faraday Future, initiates with an Outperform
FFIE Faraday Future
$2.47 /

+0.02 (+0.82%)

FFIE Faraday Future
$2.47 /

+0.02 (+0.82%)

FFIE Faraday Future
$2.47 /

+0.02 (+0.82%)

Downgrade
Informatica downgraded to Neutral from Buy at Goldman Sachs » 06:33
06/27/22
06/27
06:33
06/27/22
06:33
INFA

Informatica

$21.90 /

+1.29 (+6.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFA Informatica
$21.90 /

+1.29 (+6.26%)

INFA Informatica
$21.90 /

+1.29 (+6.26%)

04/28/22 Wells Fargo
Informatica price target lowered to $30 from $42 at Wells Fargo
04/28/22 Deutsche Bank
Informatica price target lowered to $24 from $35 at Deutsche Bank
03/14/22 RBC Capital
Informatica price target lowered to $29 from $40 at RBC Capital
02/17/22 Deutsche Bank
Informatica should be bought on any weakness, says Deutsche Bank
INFA Informatica
$21.90 /

+1.29 (+6.26%)

  • 27
    Oct
INFA Informatica
$21.90 /

+1.29 (+6.26%)

INFA Informatica
$21.90 /

+1.29 (+6.26%)

Hot Stocks
OppFi announces addition to Russell 2000 Index » 06:32
06/27/22
06/27
06:32
06/27/22
06:32
OPFI

OppFi

$3.27 /

+0.04 (+1.24%)

OppFi announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPFI OppFi
$3.27 /

+0.04 (+1.24%)

OPFI OppFi
$3.27 /

+0.04 (+1.24%)

03/11/22 Needham
OppFi price target lowered to $4.50 from $10 at Needham
03/11/22 JMP Securities
OppFi price target lowered to $6 from $10 at JMP Securities
12/22/21 DA Davidson
OppFi price target lowered to $10 from $12 at DA Davidson
09/27/21 DA Davidson
DA Davidson recommends 'getting on board' ahead of OppFi's 'inevitable recovery'
OPFI OppFi
$3.27 /

+0.04 (+1.24%)

OPFI OppFi
$3.27 /

+0.04 (+1.24%)

Upgrade
Atlassian upgraded to Buy from Neutral at Goldman Sachs » 06:32
06/27/22
06/27
06:32
06/27/22
06:32
TEAM

Atlassian

$205.38 /

+12.15 (+6.29%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan upgraded Atlassian to Buy from Neutral with a price target of $300, up from $279. The analyst has become "incrementally more positive" on Atlassian as the company reaches a "pivotal moment" in its cloud transition. He believes the company is well positioned to capitalize on the growing demand for more efficient DevOp practices across organizations. Atlassian has "only tapped a fraction" of the 2.2M companies with 10+ knowledge workers and its cloud transition is at a "compelling inflection point," Rangan tells investors in a research note.

ShowHide Related Items >><<
TEAM Atlassian
$205.38 /

+12.15 (+6.29%)

TEAM Atlassian
$205.38 /

+12.15 (+6.29%)

06/24/22 Citi
Citi names top software picks with sector de-rating 'mostly done'
05/23/22 Jefferies
Atlassian price target lowered to $180 from $275 at Jefferies
05/18/22 Wells Fargo
Atlassian price target lowered to $300 from $400 at Wells Fargo
05/16/22 Mizuho
Atlassian price target lowered to $360 from $500 at Mizuho
TEAM Atlassian
$205.38 /

+12.15 (+6.29%)

TEAM Atlassian
$205.38 /

+12.15 (+6.29%)

TEAM Atlassian
$205.38 /

+12.15 (+6.29%)

Hot Stocks
Terran Orbital set to join Russell 3000 Index » 06:31
06/27/22
06/27
06:31
06/27/22
06:31
LLAP

Terran Orbital

$5.00 /

-1.46 (-22.60%)

Terran Orbital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLAP Terran Orbital
$5.00 /

-1.46 (-22.60%)

LLAP Terran Orbital
$5.00 /

-1.46 (-22.60%)

06/15/22 BofA
Terran Orbital initiated with Buy on government demand at BofA
06/15/22 BofA
Terran Orbital initiated with a Buy at BofA
05/16/22 Canaccord
Terran Orbital price target lowered to $18 from $22 at Canaccord
04/20/22 Jefferies
Terran Orbital initiated with a Buy at Jefferies
LLAP Terran Orbital
$5.00 /

-1.46 (-22.60%)

LLAP Terran Orbital
$5.00 /

-1.46 (-22.60%)

Initiation
BofA starts Texas Roadhouse at Buy on achievable comps, attractive ROI » 06:31
06/27/22
06/27
06:31
06/27/22
06:31
TXRH

Texas Roadhouse

$76.99 /

+3.35 (+4.55%)

BofA analyst Sara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXRH Texas Roadhouse
$76.99 /

+3.35 (+4.55%)

TXRH Texas Roadhouse
$76.99 /

+3.35 (+4.55%)

06:09 Today BofA
Texas Roadhouse reinstated with a Buy at BofA
06/16/22 Citi
Texas Roadhouse price target lowered to $103 from $107 at Citi
06/09/22 Barclays
Texas Roadhouse price target lowered to $87 from $92 at Barclays
05/26/22 MKM Partners
Texas Roadhouse price target lowered to $100 from $115 at MKM Partners
TXRH Texas Roadhouse
$76.99 /

+3.35 (+4.55%)

TXRH Texas Roadhouse
$76.99 /

+3.35 (+4.55%)

Downgrade
Samsara downgraded to Neutral from Buy at Goldman Sachs » 06:31
06/27/22
06/27
06:31
06/27/22
06:31
IOT

Samsara

$12.52 /

+0.06 (+0.48%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IOT Samsara
$12.52 /

+0.06 (+0.48%)

IOT Samsara
$12.52 /

+0.06 (+0.48%)

06/16/22 Goldman Sachs
Goldman left Samsara analyst day with stronger conviction
05/31/22 RBC Capital
Samsara price target lowered to $18 from $28 at RBC Capital
03/03/22 Cowen
Samsara price target lowered to $27 from $31 at Cowen
03/03/22 Wells Fargo
Samsara price target lowered to $26 from $31 at Wells Fargo
IOT Samsara
$12.52 /

+0.06 (+0.48%)

  • 15
    Dec
IOT Samsara
$12.52 /

+0.06 (+0.48%)

IOT Samsara
$12.52 /

+0.06 (+0.48%)

Hot Stocks
Liquidia Technologies added to Russell 2000, 3000 indexes » 06:30
06/27/22
06/27
06:30
06/27/22
06:30
LQDA

Liquidia Technologies

$4.31 /

-0.31 (-6.71%)

Liquidia Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LQDA Liquidia Technologies
$4.31 /

-0.31 (-6.71%)

LQDA Liquidia Technologies
$4.31 /

-0.31 (-6.71%)

05/31/22 BTIG
Liquidia Technologies initiated with a Buy at BTIG
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
05/26/22 BofA
Liquidia Technologies initiated with a Buy at BofA
05/24/22 Jefferies
United Therapeutics price target raised to $245 from $223 at Jefferies
LQDA Liquidia Technologies
$4.31 /

-0.31 (-6.71%)

  • 15
    Apr
LQDA Liquidia Technologies
$4.31 /

-0.31 (-6.71%)

Downgrade
Alnylam downgraded to Neutral from Buy at Guggenheim » 06:30
06/27/22
06/27
06:30
06/27/22
06:30
ALNY

Alnylam

/

+

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
/

+

ALNY Alnylam
/

+

06/21/22 Piper Sandler
Ionis told Piper eplontersen efficacy competitive with Amvuttra
06/15/22 Citi
Citi opens positive '90-day Catalyst Watch' Alnylam after approval
06/14/22 Piper Sandler
Piper bullish on Alnylam as FDA approves AMVUTTRA for hATTR Polyneuropathy
06/10/22 Piper Sandler
Ionis Pharmaceuticals price target raised to $55 from $54 at Piper Sandler
ALNY Alnylam
/

+

ALNY Alnylam
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.